Medicine
Biktarvy 30 mg/120 mg/15 mg tablet
Biktarvy 30 mg/120 mg/15 mg tablet is a prescription medicine containing Bictegravir, Emtricitabine and Tenofovir alafenamide for oral use, marketed by Gilead Sciences, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store bottle below 30 °C (86 °F). Store blister pack at 25 °C (77 °F)…
Key facts
- Active ingredient (INN)
- Bictegravir, Emtricitabine and Tenofovir alafenamide
- Brand
- Biktarvy
- Strength
- 30 mg/120 mg/15 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets
- Marketing authorisation holder
- Gilead Sciences
- Manufacturer
- Gilead Sciences
- Origin register
- US FDA, United States
- Storage
- Store bottle below 30 °C (86 °F). Store blister pack at 25 °C (77 °F), excursions permitted to 15–30 °C (59–86 °F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J05AR20 Bictegravir, Emtricitabine and Tenofovir alafenamide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 7 October 2021
- Identifiers
- RxCUI 1999667, 1999673, 2584354 +1DailyMed set ID 664cb8f0-1f65-441b-b0d9-ba3d798be309NDC 61958-2505, 61958-2506Application NDA210251
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet in 1 bottle, plastic | 61958-2505-1 | Gilead Sciences | 7 October 2021 |
| 30 tablet in 1 bottle, plastic | 61958-2506-1 | Gilead Sciences | 8 October 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Bictegravir, Emtricitabine and Tenofovir alafenamide
Clinical summary
Bictegravir, Emtricitabine and Tenofovir alafenamide is a fixed-dose combination of a human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor and a hepatitis B virus nucleoside analog reverse transcriptase inhibitor. MedsAcross supplies Bictegravir, Emtricitabine and Tenofovir alafenamide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Bictegravir, Emtricitabine and Tenofovir alafenamideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Biktarvy prescribing information (Gilead Sciences) · U.S. National Library of Medicine, DailyMed
- Biktarvy: European public assessment report (EPAR) · European Medicines Agency
Need Biktarvy 30 mg/120 mg/15 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.